Product Information

RANOLAZINE ER 1,000 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.2757 per EA under NDC 63304001860. Its NADAC has been published 340 times since Aug 21, 2019.

The Low Outlier badge above means this manufacturer's average price in the Ranolazine market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

RANOLAZINE ER 1,000 MG TABLET

Ranolazine
$0.2757per EA
Low Outlier

Strength

1000 mg/1

NDC

63304001860

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

2/18/2026

Active Ingredients

RANOLAZINE

Approval Type

Generic (ANDA)

FDA Application

ANDA211707

On Market Since

5/28/2019

Pharmacological Classes

Anti-anginal
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A Inhibitors
Organic Cation Transporter 2 Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for RANOLAZINE ER 1,000 MG TABLET has been published 340 times since Aug 21, 2019, and over the history we have for it it has declined 76.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2757 per EA
All-time high$1.1472 (Oct 16, 2019)
All-time low$0.2757 (Feb 18, 2026)
52-week high$0.3633
52-week low$0.2757
Median price$0.3668
Average price$0.5145
Largest weekly change-21.2% (Mar 23, 2022)
Weeks tracked340
Tracking sinceAug 21, 2019

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

-6.7%

1Y

-24.1%

3Y

-13.7%

5Y

-54.9%

All

-76.0%

Generic Alternatives

The matcher finds 11 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of RANOLAZINE ER 1,000 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for RANOLAZINE ER 1,000 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.2757 per EA (NDC 63304001860), effective Feb 18, 2026.

How has the price of RANOLAZINE ER 1,000 MG TABLET changed over time?

Over the history we have for it, the NADAC for RANOLAZINE ER 1,000 MG TABLET has declined 76.0%. It has been tracked across 340 weekly CMS publications since Aug 21, 2019.

What are the highest and lowest recorded NADAC prices for RANOLAZINE ER 1,000 MG TABLET?

Since Aug 21, 2019, the NADAC for RANOLAZINE ER 1,000 MG TABLET has ranged from a low of $0.2757 (Feb 18, 2026) to a high of $1.1472 (Oct 16, 2019), with a median of $0.3668 per EA.

Are there cheaper alternatives to RANOLAZINE ER 1,000 MG TABLET?

11 NADAC-published products share the same active ingredient, strength, and dosage form as RANOLAZINE ER 1,000 MG TABLET, but none are currently priced below it.

Who manufactures RANOLAZINE ER 1,000 MG TABLET?

RANOLAZINE ER 1,000 MG TABLET (NDC 63304001860) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.